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We report a case of cutaneous mucormycosis and Enterobacter infection developing in a 50-year-old diabetic woman following a
dog bite that showed delayed development and diagnosis in comparison with typical zygomycotic cutaneous lesions.
1.Introduction
The zygomycetes are a class of fungi that are ubiquitous in
soil and decaying vegetable matter but can cause a variety
of infections in humans. The genera most commonly found
in human infections are Rhizopus and Mucor [1]. Infection
typically occurs in immunosuppressed patients such as
those with transplants, malignancies, and diabetes mellitus
and is usually associated with rhino-orbital-cerebral and
pulmonary disease [2]. Infection of the skin and soft tissues
with zygomycetes is the third most common diagnosis after
sinus and pulmonary forms [1]. Cutaneous zygomycosis
results from inoculation of the spores into disrupted dermis
and can occur in patients with little or no underlying
immunodeﬁciency [3–5].
2.CaseReport
A 50-year-old woman was referred to the Infectious Disease
Clinicfor nonhealing painful hand wounds, twelve days after
sustaining dog bites on the dorsum of both hands. She had a
history of insulin-dependent diabetes mellitus for two years
and hypertension. She was initially evaluated at an urgent
care centerin Rhode Island onthe dayof the dogbite.Atthat
time, she was noted to have open wounds on the dorsum of
both hands which were subsequently cleaned and stitched.
She was given a fourteen-day course of amoxicillin. Six days
after the initial dog bite, she returned to the urgent care
center to have the stitches removed. At that time, she was
noted to have an enlarged, draining nodule on the left hand.
As a result, the stitches were only removed from the right
hand. The bloody drainage from the left hand wound was
sent for culture. Three days later, nine days after initial dog
bite, she was called back to the urgent care center and was
told mold and bacteria grew in the culture and that the mold
was likelya contaminant. Atthis visit, asmall eschar replaced
the draining nodule on the dorsum of her left hand. The
stitches were removed from the left hand and a black, stringy
material was noted in the wound. This material was sent to
the microbiology laboratory for culture, and the wound was
packed. The patient continued her amoxicillin and eleven
days after the dog bite, she returned to the urgent care center
for the fourth time and once again was told that the culture
grew the same bacteria and mold, which was later identiﬁed
as Enterobacter cloacae and Mucor species (Figure 1). The
patient was referred to the Infectious Disease Clinic.
The patient denied any other unusual exposures follow-
ing the dog bites. She denied fever or chills. Her current
medications were insulin, metformin, aspirin, and lisinopril.
She had no known drug allergies. At the Infectious Disease
Clinic, her exam was remarkable for normal vital signs
and bilateral hand ulcers, left greater than right (Figure 2).
The patient was sent from the Infectious Disease Clinic to
the Emergency Department (ED) in order to be evaluated2 Case Reports in Infectious Diseases
Figure 1: Microscopic sample obtained from patient’s wounds. It
shows presence of mucor sp.
Figure 2: Ulcerative, nodular wounds on the dorsum of bilateral
hands where patient sustained dog bites. Left hand is worse than
right.
for debridement. We recommended that the patient receive
meropenem 1mg/kg and 5mg/kg of amphotericin B (lipid
complex; Abelcet; Enzon Pharmaceuticals, Bridgewater, NJ,
USA).
In the ED, the patient’s white blood cell (WBC) was
7900/uL, with a normal diﬀerential and normal chemistry
panel. Her hemoglobin A1c was 7.8%. Blood cultures were
drawn, which were negative for growth. Within three hours
of arrival to the ED, the patient was taken to the Operating
Room (OR) for debridement of left dorsal hand wound. The
surgeons debrided down through the subcutaneous tissue to
the level of the peritenon, which are the connective tissue
structures attached to and surround the tendon (Figure 3).
The specimen was sent to pathology and microbiology. This
time, the cultures did not grow. The pathologist found
chronic active ulcer and organizing abscess in the surgical
specimen.
Three days after surgical debridement, the patient’s
woundwashealingwell,andherintravenousantibioticswere
switched to ciproﬂoxacin 500mg orally every twelve hours
for two weeks and posaconazole 100mg orally every twelve
hours for two weeks.
Figure 3: Patient’s left hand following surgical debridement.
3.Discussion
The presence of more than one organism isolated from a
wound following a dog bite is not unusual, but the presence
of Mucor sp is atypical. The most common bacteria found in
a dog’s mouth include: Staphylococcus species, Streptococcus
species, Eikenella species, Pasteurella species, Proteus species,
Klebsiella species, Enterobacter species, and Capnocytophaga
canimorsus [6]. Thus, the Enterobacter infection likely came
from bacteria already in the dog’s mouth. We postulate that
this patient’s fungal infection may have resulted from the
dog’s mouth being contaminated with soil that contained
Mucor sp. Alternatively,the patient could have contaminated
h erw oun dwiths oilf r omh ery a r d.H o w ev er ,th ela tt ers eem s
less likely, as the patient did not recall putting her hands
in soil after the dog bite. Infection with zygomycetes has
also been associated with contaminated traumatic wounds,
dressings and splints, burns, and surgical sites [3–5]. This
case is signiﬁcant, because it is diﬃcult to ﬁnd case reports
in the literature of polymicrobial infection involving Mucor
sp. following a dog bite. Additionally, previous case reports
of cutaneous zygomycosis involve patients with greater
immunosuppression [7, 8] although cutaneousmucormyco-
sis can occur in patients with little or no immunodeﬁciency
[9]. Our patient had diabetes, but her glucose level was
moderately controlled with a hemoglobin A1c less than 8%.
The development and diagnosis of cutaneous zygomy-
cosis was also delayed in this case compared to its more
rapid development in immunosuppressed patients [7, 8].
The diagnosis is often made on clinical grounds and can
be very challenging; tissue biopsy for histology and culture
is usually needed [3]. The gross appearance of skin lesions
infected with Mucor sp. varies but most often causes an
ulcerative lesion with eschar formation [10], as it did in our
patient. Lesions consistent with cutaneous zygomycosis were
ﬁrst noted 9 days after the patient’s dog bite. The ﬁrst time
Mucor sp was isolated from our patient, it was thought to be
acontaminantandthuswas nottreatedimmediately,causing
a delay in diagnosis and appropriate treatment. Finding
the same organism twice did prompt medical personnel to
reconsider the diagnosis of fungal infection in this patient
who was not responding to appropriate medical therapy.Case Reports in Infectious Diseases 3
The best outcomes from cutaneous zygomycosis have
been associated with early detection, aggressive surgical
debridement, early use of eﬀective antifungal therapy, and
correction of predisposing factors [11]. Although intra-
venous amphotericin B (lipid formulation) is the drug of
choice initially, oral posaconazole is used as step-down
therapy for patients who have responded to amphotericin
B[ 12]. Despite early diagnosis and aggressive combined
surgical and medical therapy, the prognosis for recovery
from zygomycosis is poor with the exception of cutaneous
involvement, which rarely disseminates [11]. First-line oral
antibiotic therapy following a dog bite is amoxicillin-
clavulanic acid for 10 days, which was appropriately given to
the patient. Unfortunately, amoxicillin-clavulanic acid is not
eﬀective against mold, and thus did not treat our patient’s
fungal infection. Diagnosis of Mucor sp as a pathogen in the
wound infection would have resulted in a more appropriate
antibiotic earlier in her treatment course.
4.Conclusion
In conclusion, this case highlights the importance of dili-
gencein collecting microbiologicdata when there is minimal
clinicalresponse to empiric antibiotics. In any patient,where
there is a possibility of soil contamination and the presence
of an advancing necrotic indurated lesion, consideration of
z y g o m y c o s i sa st h ed i a gn o s i ss h o u l db em a d e .I ti si m p o r t a n t
to consider the microbiologic results before dismissing them
as contamination and recognize mold as an important and
potential pathogen. The patient was taking amoxicillin for
several days without clinical improvement, and it became
critical that cultures were taken in order to establish the
diagnosis. Lastly, this patient received a referral from the
urgent care center to an infectious disease specialist and
had a surgical evaluation and debridement. Because all of
thesecriticalsteps(obtainingcultures,infectiousdisease,and
surgical consultations) were taken during the care of this
patient, she had a good outcome.
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